Status:

TERMINATED

Resistance Training and Cardiometabolic Health

Lead Sponsor:

Arizona State University

Conditions:

Insulin Sensitivity

Endothelial Dysfunction

Eligibility:

All Genders

18-55 years

Phase:

NA

Brief Summary

This study will investigate the relationship between resistance training load and repetitions on cardiometabolic outcomes. The primary objective of this clinical trial is to determine whether high loa...

Detailed Description

While it has been firmly established that aerobic exercise training is an effective modality for managing cardiometabolic disease risk, the influence of resistance training (RT) is not as well charact...

Eligibility Criteria

Inclusion

  • Male and female
  • 18-55 years of age
  • BMI 25-40
  • No recent history of starting a structured exercise program or diet in the last 3 months

Exclusion

  • Current smoker and/or recreational drug user
  • Answers "yes" to one or more questions on the Physical Activity Readiness Questionnaire
  • Diagnosed diabetes, heart disease
  • History of anabolic steroid use in the past six months
  • Taking medications for treatment of diabetes, heart disease, and hypertension.
  • Orthopedic or musculoskeletal contraindications to resistance training
  • Unwilling to follow any aspect of the study protocol including blood sampling and weight training

Key Trial Info

Start Date :

September 21 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 31 2020

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT03325933

Start Date

September 21 2017

End Date

August 31 2020

Last Update

April 19 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Arizona State University

Phoenix, Arizona, United States, 85004